Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. A review of pre-clinical and clinical investigations.

Source:http://linkedlifedata.com/resource/pubmed/id/2193121

Download in:

View as

General Info

PMID
2193121